All Oncology News

The OncLive® News page includes the latest in clinical oncology news, including breaking regulatory decisions, clinical trial findings, pivotal and practice-changing data published in academic peer-reviewed journals, and more across solid and hematologic malignancies. Regulatory news includes new drug approvals by the FDA and European Union, priority review and breakthrough therapy designations, and orphan drug and fast track statuses.

Pap Test May Detect Ovarian and Endometrial Cancers

January 10th 2013

New research has found that Papanicolaou smear tests that collect DNA in addition to providing a routine cytologic evaluation may be able to identify mutations associated with ovarian and endometrial cancers.

Introducing the UC Davis Lung Cancer Chat Room

January 10th 2013

The UC Davis Lung Cancer Chat Room is an interactive meeting of learning and support for patients, families, friends and caregivers affected by lung cancer.

Potential Targets in Ovarian Cancer Identified

January 8th 2013

Researchers have identified the molecular basis behind two concepts in ovarian cancer that allow tumor stem cells to survive and proliferate even after treatment.

Improving Survivorship

January 8th 2013

ASCO issues recommendations for improving cancer survivorship care.

Sorafenib Improves PFS in Thyroid Cancer

January 3rd 2013

A phase III trial of sorafenib in patients with locally advanced or metastatic RAI-refractory differentiated thyroid cancer met its primary endpoint of a statistically significant improvement in PFS.

Tumor Boards

January 3rd 2013

Surprising findings about tumor board effectiveness in the VA system.

"Fiscal Cliff" Deal Averts Severe Cuts to Medicare and Cancer Research

January 2nd 2013

After wrangling between Democrats and Republicans pushed a decision beyond a year-end deadline, the federal government passed the American Taxpayer Relief Act of 2012 and averted the "fiscal cliff."

Novel Cancer Vaccine Fails To Significantly Improve Overall Survival in Lung Cancer

December 21st 2012

Results of a large phase III trial testing the efficacy of the investigational vaccine L-BLP25 in patients with advanced lung cancer found that the vaccine failed to show a statistically significant improvement in overall survival

Ponatinib Granted Early Approval for Rare Leukemias

December 14th 2012

Acting 3 months ahead of schedule, the FDA approved ponatinib for the treatment of patients with all phases of CML and Ph+ALL that is resistant or intolerant to prior TKIs.

Another Year at the Top

December 11th 2012

Nurses again rank highest in Gallup's survey on honesty and ethical standards.

FDA Approves Earlier Use of Abiraterone Acetate

December 10th 2012

The FDA has approved abiraterone acetate in combination with prednisone prior to chemotherapy for the treatment of men with metastatic castration-resistant prostate cancer.

Pancreatic Cancer

December 3rd 2012

Of the 10 most lethal cancers, it's the only one with a single digit survival rate.

FDA Approves Cabozantinib for Medullary Thyroid Cancer

November 29th 2012

The FDA approved cabozantinib, a multi-targeted tyrosine kinase inhibitor, for the treatment of metastatic medullary thyroid cancer.

Cancer-related Fatigue

November 26th 2012

Updated Cochrane review supports the benefits of aerobic exercise.

2012 Survey of RNs Released

November 13th 2012

Since last year, there has been significant improvement in career satisfaction.

FDA Grants Orphan Drug Status to Amatuximab for Malignant Pleural Mesothelioma

November 12th 2012

Amatuximab has received orphan drug status from the FDA to treat patients with malignant pleural mesothelioma, the most common form of mesothelioma.

Skin Exams

November 5th 2012

YouTube video provides guidance on assessing for skin cancer.

FDA Approves Synribo for CML

October 26th 2012

The FDA has approved omacetaxine mepesuccinate for the treatment of adult patients with Philadelphia chromosome-positive CML who have progressed after treatment with at least two prior TKIs.

Potential Biomarker for Response to Bevacizumab in Colorectal Cancer Identified

October 25th 2012

Researchers have identified a potential predictive marker for survival in cases of metastatic colorectal cancer treated with bevacizumab.

Overuse of Procedures and Treatments

October 24th 2012

National summit convened to reduce overuse of unnecessary procedures and treatments.